Status: current, Defined. Date: 30-Apr 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4808911000168115 | PKU Sphere20 (glycomacropeptide formula with docosahexaenoic acid and low phenylalanine) oral liquid, 15 x 237 mL bottles (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4808921000168110 | PKU Sphere20 oral liquid, 15 x 237 mL bottles | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| PKU Sphere20 oral liquid, 15 x 237 mL bottles | Is a | glycomacropeptide formula with docosahexaenoic acid and low phenylalanine oral liquid, 15 x 237 mL bottles | true | Inferred relationship | Some | ||
| PKU Sphere20 oral liquid, 15 x 237 mL bottles | Is a | trade product pack | true | Inferred relationship | Some | ||
| PKU Sphere20 oral liquid, 15 x 237 mL bottles | has TP | PKU Sphere20 | true | Inferred relationship | Some | ||
| PKU Sphere20 oral liquid, 15 x 237 mL bottles | has TPUU | PKU Sphere20 oral liquid, 237 mL bottle | true | Inferred relationship | Some | 572156407 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| PKU Sphere20 oral liquid, 15 x 237 mL bottles | Is a | True | PKU Sphere20 oral liquid, 15 x 237 mL bottles | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR